Your session is about to expire
← Back to Search
Inhaled Nitric Oxide for Traumatic Brain Injury
Study Summary
This trial will test whether iNO can reduce TBI damage by increasing cerebral blood flow and improving patient outcomes.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I experienced memory loss for a day after an injury.I do not have severe heart problems.I currently have a respiratory infection.I have a large brain bleed.I needed CPR or a shock to my heart when I was admitted.I am either male or female.I am between 18 and 75 years old.My kidney function is reduced.I have a diagnosed brain blood vessel condition.I have ARDS or had high blood pressure in my lungs before.I am somewhat alert or fully alert with a concerning brain scan.I need surgery for a brain or nerve condition now.
- Group 1: Group A
- Group 2: Group B
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What are the enrollment qualifications for this research endeavor?
"To participate in this medical study, applicants must have suffered traumatic brain injury and possess an age between 18 to 75 years. The total number of patients accepted is 38."
Are there any opportunities for individuals to join this clinical trial?
"The profile on clinicaltrials.gov states that this trial is not actively seeking participants, despite being initially posted on August 1st 2023 and last modified November 8th 2022. However, there are still 899 other medical studies presently recruiting individuals for their trials."
Is the eligibility criteria of this research limited to individuals aged 45 or younger?
"According to the prerequisites for this clinical trial, the minimum age of enrolment is 18 and there is an upper limit set at 75."
Has Group B been granted approval by the Food and Drug Administration?
"Group B received a rating of 2 on the safety scale due to its status as a Phase 2 trial, which implies that there is sufficient evidence proving its security but not yet any data indicating its efficacy."
Who else is applying?
What state do they live in?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger